Purine metabolism in normal and pathologic lymphoid cell differentiation
暂无分享,去创建一个
[1] S. K. Wadman,et al. The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. , 1984, Journal of immunology.
[2] G. Spierenburg,et al. Purine Interconversion Pathways in T, B, Tγ and T-Tγ Cells from Human Peripheral Blood , 1984 .
[3] W. Kuis,et al. Mononuclear cells in S-phase in a patient with purine nucleoside phosphorylase deficiency. , 1984, Advances in experimental medicine and biology.
[4] C. Figdor,et al. Lymphocyte Maturation in the Human Thymus , 1983, Scandinavian journal of immunology.
[5] E. Gelfand,et al. Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. , 1983, The Journal of biological chemistry.
[6] A. Hoffbrand,et al. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post‐thymic T cells , 1983, British journal of haematology.
[7] G. Janossy,et al. The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation. , 1983, Immunology today.
[8] R. Watts. Purine enzymes and immune function. , 1983, Clinical Biochemistry.
[9] G. Spierenburg,et al. Enzymological studies in chronic lymphocytic leukemia. , 1983, Leukemia research.
[10] G. Spierenburg,et al. Purine metabolism in childhood acute lymphoblastic leukemia: biochemical markers for diagnosis and chemotherapy. , 1983, Leukemia research.
[11] W. Nyhan,et al. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin , 1982 .
[12] D. Carson,et al. Characterization of an adenosine 5'-triphosphate- and deoxyadenosine 5'-triphosphate-activated nucleotidase from human malignant lymphocytes. , 1982, Cancer research.
[13] J. Hadden,et al. Cyclic nucleotides in mitogen-induced lymphocyte proliferation. , 1982, Immunology today.
[14] Hoffbrand Av,et al. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes. , 1982 .
[15] G. Janossy,et al. Enzymes of purine metabolism in human peripheral lymphocyte subpopulations. , 1982, Clinical and experimental immunology.
[16] G. Janossy,et al. Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. , 1982, Journal of immunology.
[17] P. Bunn,et al. Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T‐cell lymphoma , 1982, British journal of haematology.
[18] R. Kefford,et al. S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes. , 1982, Cancer research.
[19] A. Piga,et al. The effects of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells , 1982, British journal of haematology.
[20] K. Foon,et al. Surface markers on leukemia and lymphoma cells: recent advances. , 1982, Blood.
[21] P. Gearhart. Generation of immunoglobulin variable gene diversity. , 1982, Immunology today.
[22] M. Hershfield,et al. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[23] Y. Richard,et al. The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies. , 1982, Leukemia research.
[24] C. Bruyn,et al. Purine metabolism in relation to leukemia and lymphoid cell differentiation. , 1982 .
[25] A. Piga,et al. THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA , 1981, The Lancet.
[26] B. Mitchell,et al. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. , 1981, Science.
[27] I. Taylor,et al. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine. , 1981, Cancer research.
[28] A. Piga,et al. Studies on the Biochemical Sequelae of Therapy in Thy‐Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’Deoxycoformycin , 1981, British journal of haematology.
[29] M. Tattersall,et al. Ecto-adenosine triphosphatase deficiency in cultured human T and null leukemic lymphocytes. A biochemical basis for thymidine sensitivity. , 1981, The Journal of clinical investigation.
[30] J. Kaye,et al. The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts. , 1981, Journal of immunology.
[31] J. Habeshaw,et al. Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes. , 1981, Leukemia research.
[32] H. Dosch,et al. The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation. , 1980, Journal of immunology.
[33] B. Mitchell,et al. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms. , 1980, Annals of internal medicine.
[34] L. Parker,et al. High-dose thymidine infusions in patients with leukemia and lymphoma. , 1980, Blood.
[35] S. Howell,et al. Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemia. , 1980, Blood.
[36] D. Baltimore. Is terminal deoxynucleotidyl transferase a somatic mutagen in lymphocytes? , 1974, Nature.
[37] H. Müller-Hermelink,et al. Characterization of the B-cell and T-cell regions of human lymphatic tissue through enzyme histochemical demonstration of ATPase and 5′-nucleotidase activities , 1974, Virchows Archiv. B, Cell pathology.